Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.
Last trade$19.34
Day change-$0.50 (-2.52%)
Day range$19.30 – $19.94
Volume2,360,709
Market cap$13.68B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$13.68B
Price / earnings
36.27×
Price / book
1.74×
Price / sales
4.62×
EV / sales
7.62×
EV / EBITDA
13.74×
Profitability
Earnings per share
$0.55
Return on assets
1.68%
Return on equity
4.8%
Dividend yield
6.17%
Liquidity and leverage
Debt / equity
1.19×
Current ratio
0.19×
Quick ratio
0.19×
Cash ratio
0.1×
Cash flow
Price / cash flow
10.77×
Price / free cash flow
—
Free cash flow
-$2.14B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for DOC, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$813.69M
$749.81M
$738.78M
$657.62M
$690.34M
$678.54M
$687.07M
$653.21M
Cost of revenue
$0
$333.12M
$0
-$841.25M
$0
$276.18M
$0
-$797.84M
Gross profit
$813.69M
$416.69M
$738.78M
$1.5B
$690.34M
$402.36M
$687.07M
$1.45B
Selling, general and administrative
$23.59M
$22.52M
$24.59M
$23.63M
$19.91M
$20.76M
$26.12M
$23.93M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$711.43M
$315.08M
$660.06M
$1.42B
$576.51M
$296.9M
$569.78M
$1.4B
Operating income
$102.26M
$101.61M
$78.72M
$77.48M
$113.83M
$105.47M
$117.29M
$55.58M
Interest expense
-$83.9M
-$92.28M
-$87.29M
-$80.64M
-$76.78M
-$75.06M
-$72.69M
-$70.51M
Income before taxes
$37.97M
$59.33M
$195.65M
$125.11M
-$111.05M
$39.65M
$54.29M
-$3.23M
Income taxes
$1.29M
-$1.4M
$254K
$6.03M
-$1.21M
$2.38M
$2.08M
-$14.01M
Net income
$36.69M
$63.24M
$199.66M
$121.79M
-$109.85M
$39.02M
$50.06M
$10.67M
Net income attributable to common shareholders
$17.12M
$52.67M
$193.48M
$113.97M
-$117.26M
$31.56M
$42.36M
$4.55M
EBITDA
$423.62M
$381.27M
$390.33M
$446.36M
$398.81M
$361.3M
$387.81M
$441.18M
Basic earnings per share
$0.02
$0.08
$0.28
$0.16
-$0.17
$0.05
$0.06
$0.01
Diluted earnings per share
$0.02
$0.08
$0.28
$0.16
-$0.17
$0.05
$0.06
$0.01
Recent news
Company coverage with links to the original publishers.
Healthpeak Properties raised full-year earnings guidance by $0.05 per share following strong Q3 2026 results. The company is acquiring discounted lab buildings near existing campuses with 41% occupancy, targeting 9-10% stabilized yields. Life science lab occupancy increased 270 basis points year-to-date as AI and robotics firms enter the market. Healthpeak recycled nearly $2 billion from outpatient asset sales to fund higher-yielding reinvestments, demonstrating disciplined capital management and positioning itself as a consolidator in major research hubs.
Healthpeak Properties (DOC) reported Q3 2026 FFOA of $0.44 per share, beating estimates by 2.3%, with revenues up 16.3% YoY to $820.9 million. The company raised 2026 FFOA guidance to $1.76-$1.78 per share, supported by solid outpatient leasing, improving lab occupancy, and strong senior housing performance from Janus Living. However, operating expenses surged 30% YoY, and the company carries a Zacks Rank #4 (Sell) rating.
Healthpeak reported Q3 2026 revenue of $820.89 million, beating Wall Street estimates of $758.25 million by 8.26%, with EPS of $0.44 versus consensus of $0.43. While the company showed strong revenue growth of 16.3% year-over-year and beat on several key metrics including resident fees and lab revenues, it underperformed on outpatient medical NOI and interest income. The stock carries a Zacks Rank #4 (Sell) rating and has underperformed the broader market over the past month.
Healthpeak Properties (DOC) is expected to report Q3 2026 revenues of $758.3 million, up 7.4% year-over-year, but FFOA per share is projected to decline 6.5% to 43 cents. While improving senior housing demand and lab leasing activity may provide support, elevated interest expenses, competitive pressures, and declining rental revenues are expected to weigh on results.
The article explains how to identify stocks poised for positive earnings surprises using the Zacks Earnings ESP (Expected Surprise Prediction) tool, which compares the most recent analyst estimates against consensus estimates. When combined with a Zacks Rank #3 or better, stocks with positive ESP have historically produced positive surprises 70% of the time with 28.3% average annual returns. Two finance stocks highlighted as examples are Healthpeak (DOC) and Victory Capital Holdings (VCTR), both with positive ESP figures ahead of their November earnings reports.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$0.1017 per share
Declared
Oct 1, 2026
Ex-dividend
Dec 18, 2026
Pay date
Dec 30, 2026
Ex-dividend
Amount / share
Pay date
Type
Nov 13, 2026
$0.1017
Nov 25, 2026
recurring
Oct 19, 2026
$0.1017
Oct 30, 2026
recurring
Sep 14, 2026
$0.1017
Sep 25, 2026
recurring
Aug 17, 2026
$0.1017
Aug 28, 2026
recurring
Jul 20, 2026
$0.1017
Jul 31, 2026
recurring
Stock splits
Historical share-structure events and their execution dates.